Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs41276738
rs41276738
VWF
0.730 GeneticVariation BEFREE The prevalence of type 2N in our VWD cohort was 2.5%, and 5.2% of the general population in Northeast Italy was found heterozygous for the p.R854Q mutation. 29115006

2018

dbSNP: rs41276738
rs41276738
VWF
0.730 GeneticVariation BEFREE These data strongly suggest a founder effect, with a single R854Q mutation event being the cause of the type 2N von Willebrand's disease in our cohort of patients. 22875612

2013

dbSNP: rs41276738
rs41276738
VWF
0.730 GeneticVariation BEFREE Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide. 16953269

2006

dbSNP: rs41276738
rs41276738
VWF
T 0.730 CausalMutation CLINVAR

dbSNP: rs121964894
rs121964894
VWF
A 0.700 CausalMutation CLINVAR

dbSNP: rs61748477
rs61748477
VWF
A 0.700 CausalMutation CLINVAR

dbSNP: rs61748478
rs61748478
VWF
C 0.700 CausalMutation CLINVAR

dbSNP: rs61748497
rs61748497
VWF
G 0.700 CausalMutation CLINVAR

dbSNP: rs61754002
rs61754002
VWF
T 0.700 CausalMutation CLINVAR

dbSNP: rs62643630
rs62643630
VWF
A 0.700 CausalMutation CLINVAR

dbSNP: rs61748469
rs61748469
VWF
0.010 GeneticVariation BEFREE We conclude that R763G is a new type 2N VWD mutation located in the VWF propeptide which alters the proteolytic processing of VWF and consequently its binding to FVIII. 16953269

2006

dbSNP: rs530641616
rs530641616
0.010 GeneticVariation BEFREE The common von Willebrand disease type 2N mutation (R91Q) was excluded as a modifying factor in these groups of patients. 8695835

1996

dbSNP: rs568202260
rs568202260
0.010 GeneticVariation BEFREE The common von Willebrand disease type 2N mutation (R91Q) was excluded as a modifying factor in these groups of patients. 8695835

1996

dbSNP: rs751205634
rs751205634
0.010 GeneticVariation BEFREE The common von Willebrand disease type 2N mutation (R91Q) was excluded as a modifying factor in these groups of patients. 8695835

1996